导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 4.25% | 408/1050 |
| 近一周 | -1.52% | 228/1104 |
| 近一月 | -7.18% | 842/1102 |
| 近一季 | -19.68% | 969/1092 |
| 近半年 | -1.15% | 450/1070 |
| 近一年 | 23.93% | 195/1018 |
| 近两年 | 77.99% | 300/926 |
| 近三年 | 50.90% | 250/834 |
| 成立以来 | 475.80% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.44% 680/1070 |
56.11% 194/1101 |
- - |
- - |
| 2025 | 47.17% 225/1065 |
-0.43% 822/1014 |
-1.25% 792/1038 |
29.58% 362/1050 |
15.51% 20/1065 |
| 2024 | 3.23% 494/1011 |
0.53% 288/960 |
-0.30% 324/983 |
8.97% 717/991 |
-5.48% 695/1011 |
| 2023 | -24.26% 764/952 |
-0.89% 660/880 |
0.77% 148/895 |
-18.44% 842/915 |
-7.01% 678/952 |
| 2022 | -27.46% 567/867 |
-17.44% 390/773 |
6.80% 420/806 |
-9.28% 201/845 |
-9.31% 768/867 |
| 2021 | 32.52% 59/740 |
-7.33% 432/580 |
21.12% 147/659 |
14.62% 37/704 |
3.01% 305/740 |
| 2020 | 101.88% 28/554 |
1.55% 123/419 |
26.82% 166/466 |
18.39% 73/517 |
32.40% 35/554 |
| 2019 | 60.75% 76/410 |
28.99% 430/1149 |
-1.99% 525/1231 |
11.86% 83/390 |
13.67% 80/410 |
| 2018 | -33.64% 258/349 |
- - |
- - |
- - |
-16.89% 948/1080 |
| 2017 | 26.84% 54/285 |
- - |
- - |
- - |
- - |
| 2016 | -17.30% 102/205 |
- - |
- - |
- - |
- - |
| 2015 | 69.77% 9/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 建信改革红利股票A VS. 东吴新产业精选股票A(580008) |